[
  {
    "ts": null,
    "headline": "Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Viatris (VTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=d29cac1533e993b503f3126fe42156f8fee7ab806304103ec035bf8f2994bd44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761063002,
      "headline": "Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?",
      "id": 137181111,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris (VTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=d29cac1533e993b503f3126fe42156f8fee7ab806304103ec035bf8f2994bd44"
    }
  },
  {
    "ts": null,
    "headline": "How Viatris is Fighting Infectious Disease",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / October 21, 2025 / Viatris has a long history in the fight against infectious disease, which accounts for eight of the top 10 causes of death in low-income countries.1 We are working with global and local partners ...",
    "url": "https://finnhub.io/api/news?id=f2f11f872ce94e7fa08f7b76ffe81500bfb5f8d426bdfefd3c115dd9e7f63c60",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761054300,
      "headline": "How Viatris is Fighting Infectious Disease",
      "id": 137178717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / October 21, 2025 / Viatris has a long history in the fight against infectious disease, which accounts for eight of the top 10 causes of death in low-income countries.1 We are working with global and local partners ...",
      "url": "https://finnhub.io/api/news?id=f2f11f872ce94e7fa08f7b76ffe81500bfb5f8d426bdfefd3c115dd9e7f63c60"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
    "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
    "url": "https://finnhub.io/api/news?id=e18f1aad372002f6f1de6bb282fbff19302e111480270217bdb79caea5beae70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761040378,
      "headline": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
      "id": 137178457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
      "url": "https://finnhub.io/api/news?id=e18f1aad372002f6f1de6bb282fbff19302e111480270217bdb79caea5beae70"
    }
  }
]